| Label | Description |
|
|---|---|---|---|
Assessment of AAV serotypes 6, 8 and 9 for targeting pancreatic innervation. | |||
The Common Fund’s Stimulating Peripheral Activity to Relieve Conditions (SPARC) program seeks to acc... | |||
A subject from SPARC produced as part of the OT2OD024912 project | |||
A biosample from SPARC produced as part of the OT2OD024912 project | |||
A subject from SPARC produced as part of the OT2OD024912 project | |||
Quantification of CTB in coeliac, nodose, and dorsal root ganglia 1 week after intrapancreatic injec... | |||
A biosample from SPARC produced as part of the OT2OD024912 project | |||
A subject from SPARC produced as part of the OT2OD024912 project | |||
A subject from SPARC produced as part of the OT2OD024912 project | |||
A subject from SPARC produced as part of the OT2OD024912 project |
Assessment of AAV serotypes 6, 8 and 9 for targeting pancreatic innervation.
The Common Fund’s Stimulating Peripheral Activity to Relieve Conditions (SPARC) program seeks to acc...
A subject from SPARC produced as part of the OT2OD024912 project
A biosample from SPARC produced as part of the OT2OD024912 project
A subject from SPARC produced as part of the OT2OD024912 project
Quantification of CTB in coeliac, nodose, and dorsal root ganglia 1 week after intrapancreatic injec...
A biosample from SPARC produced as part of the OT2OD024912 project
A subject from SPARC produced as part of the OT2OD024912 project
A subject from SPARC produced as part of the OT2OD024912 project
A subject from SPARC produced as part of the OT2OD024912 project